Papers - YAMAMOTO Hayato
-
Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.
Sato T, Yoneyama T, Tobisawa Y, Hatakeyama S, Yamamoto H, Kojima Y, Mikami J, Mori K, Hashimoto Y, Koie T, Ohyama C
Biochemical and biophysical research communications 470 ( 1 ) 150 - 156 2016.1
-
Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.
Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
PloS one 11 ( 3 ) e0151742 2016
-
Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.
Sato T, Hatakeyama S, Okamoto T, Yamamoto H, Hosogoe S, Tobisawa Y, Yoneyama T, Hashiba E, Yoneyama T, Hashimoto Y, Koie T, Hirota K, Ohyama C
PloS one 11 ( 5 ) e0153961 2016
-
Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.
Hamano I, Hatakeyama S, Yoneyama T, Tobisawa Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C
SpringerPlus 5 ( 1 ) 1917 2016
-
Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].
Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
PloS one 11 ( 2 ) e0149544 2016
-
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
Koie T, Ohyama C, Hosogoe S, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K
International urology and nephrology 47 ( 9 ) 1509 - 14 2015.9
-
Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.
Koie T, Ohyama C, Yoneyama T, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K
BMC urology 15 32 2015.4
-
Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.
Yoneyama T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y, Koie T, Ohyama C
International journal of clinical oncology 20 ( 2 ) 369 - 74 2015.4
-
Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.
Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y
Medical oncology (Northwood, London, England) 32 ( 1 ) 421 2015.1
-
A case of primary renal carcinoid tumor.
Tanaka T, Yamamoto H, Imai A, Shingo H, Yoneyama T, Koie T, Hashimoto Y, Ohyama C
Case reports in urology 2015 736213 2015
-
[Leiomyosarcoma of the prostate treated with neoadjuvant intra-arterial chemotherapy and pelvic excenteration ; a case report].
Noro D, Yoneyama T, Hagiwara K, Mori K, Yamamoto H, Hashimoto Y, Koie T, Ohyama C
Hinyokika kiyo. Acta urologica Japonica 60 ( 11 ) 579 - 82 2014.11
-
Testicular metastasis of prostate cancer: a case report.
Kusaka A, Koie T, Yamamoto H, Hamano I, Yoneyama T, Hashimoto Y, Ohyama C, Tobisawa Y, Yoneyama T
Case reports in oncology 7 ( 3 ) 643 - 7 2014.9
-
Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Kitayam M, Hirota K
Urologic oncology 32 ( 6 ) 820 - 5 2014.8
-
Invadopodia are essential in transurothelial invasion during the muscle invasion of bladder cancer cells.
Imanishi K, Yoneyama MS, Hatakeyama S, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S
Molecular medicine reports 9 ( 6 ) 2159 - 65 2014.6
-
Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.
Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y
Medical oncology (Northwood, London, England) 31 ( 5 ) 949 2014.5
-
Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.
Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Aoki M, Takai Y
World journal of surgical oncology 12 134 2014.4
-
Extravasation during bladder cancer metastasis requires cortactin‑mediated invadopodia formation.
Tokui N, Yoneyama MS, Hatakeyama S, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S
Molecular medicine reports 9 ( 4 ) 1142 - 6 2014.4
-
A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.
Iwamura H, Hatakeyama S, Tanaka Y, Tanaka T, Tokui N, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Ohyama C
BMC research notes 7 64 2014.1
-
Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient.
Narita T, Hamano I, Kusaka A, Murasawa H, Tokui N, Imanishi K, Okamoto T, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C, Hakamada K
Case reports in oncology 7 ( 1 ) 233 - 8 2014.1
-
A Case of Malignant Pheochromocytoma Detected during Fertility Treatment.
Hagiwara K, Hamano I, Kusaka A, Murasawa H, Tokui N, Imanishi K, Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C
Case reports in urology 2014 646743 2014